Expression of human endogenous retrovirus ERV3 (HERV-R) mRNA in normal and neoplastic tissues

International Journal of Oncology

Volumn 12, Issue 2, 1998, Pages 309-313

  Andersson, Ann Catrin ^a   Svensson, Ann Cathrin ^b   Rolny, Charlotte ^a   Andersson, Göran ^b   Larsson, Erik ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

ERV3; Human endogenous retrovirus; Human tissues

Indexed keywords

MESSENGER RNA;

ARTICLE; CANCER TISSUE; CELL SPECIFICITY; CHORIOCARCINOMA; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LUNG CARCINOMA; NORTHERN BLOTTING; PRIORITY JOURNAL; RETROVIRUS; VIRUS GENOME;

EID: 0031910368     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.12.2.309     Document Type: Article

References (24)

1. Larsson E, Kato N and Cohen M: Human endogenous proviruses. Curr Top Microbiol Immunol 148: 115-132, 1989.
2. Leib-Mösch C, Brack-Werner R, Werner T, Bachmann M, Faff O, Erfle V and Hehlmann R: Endogenous retroviral elements in human DNA. Cancer Res 50 (Suppl. I): 5636-5642, 1990.
3. Wilkinson DA, Mager DL and Leong J-AC: Endogenous human retroviruses. In: The Retroviridae. Levy JA (ed). Vol. 3. Plenum Press, New York, pp465-535, 1994.
4. Krieg AM and Steinberg AD: Retroviruses and autoimmunity. J Autoimmunity 3: 137-166, 1990.
5. O'Connell C, O'Brien S, Nash WG and Cohen M: ERV3, a full-length human endogenous provirus: chromosomal localization and evolutionary relationships. Virology 138: 225-235, 1984.
6. Kato N, Pfeifer-Ohlsson S, Kato M, Larsson E, Rydnert J, Ohlsson R and Cohen M: Tissue-specific expression of human provirus ERV3 mRNA in human placenta: two of the three ERV3 mRNAs contain human cellular sequences. J Virol 61: 2182-2191, 1987.
7. Feinberg AP and Vogelstein B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132: 6-13, 1983.
8. Holmgren L, Flam F, Larsson E and Ohlsson R: Successive activation of the platelet-derived growth factor ß receptor and platelet-derived growth factor B genes correlates with the genesis of human choriocarcinoma. Cancer Res 53: 2927-2931, 1993.
9. Cohen M, Kato N and Larsson E: ERV3 human endogenous provirus mRNAs are expressed in normal and malignant tissues and cells, but not in choriocarcinoma tumor cells. J Cell Biochem 36: 121-128, 1988.
10. Larsson E, Andersson A-C and Nilsson BO: Expression of an endogenous retrovirus (ERV3 HERV-R) in human reproductive and embryonic tissues-evidence for a function for envelope gene products. Uppsala J Med Sci 99: 113-120, 1994.
11. Andersson A-C, Merza M, Venables PJW, Pontén F, Sundström J, Cohen M and Larsson E: Elevated levels of the endogenous retrovirus ERV3 in sebaceous glands. J Invest Dermatol 106: 125-128, 1996.
12. Lerner RA, Wilson CB, del Villano BC, McConahey PJ and Dixon FJ: Endogenous oncornaviral gene expression in adult and fetal mice: quantitative, histologic and physiologic studies of the major viral glycoprotein, gp70. J Exp Med 143: 151-166, 1976.
13. Löwer R, Löwer J and Kurt R: The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc Natl Acad Sci USA 93: 5177-5184, 1996.
14. Larsson E, Venables PJW, Andersson A-C, Fan W, Rigby S, Botling J, Öberg F, Cohen M and Nilsson K: Expression of the endogenous retrovirus ERV3 (HERV-R) during induced monocytic differentiation in the U-937 cell line. Int J Cancer 67: 451-456, 1996.
15. Boyd MT, Bax CMR, Bax BE, Bloxam DL and Weiss RA: The human endogenous retrovirus ERV3 is upregulated in differentiating placental trophoblast cells. Virology 196: 905-909, 1993.
16. Takeuchi K, Katsumata K, Ikeda H, Minami M, Wakisaka A and Yoshiki T: Expression of endogenous retroviruses, ERV3 and λ4-1, in synovial tissues from patients with rheumatoid arthritis. Clin Exp Immunol 99: 338-344, 1995.
17. Sluyser M, Verstraeten RA and van Nie R: Effect of hormones on the expression of proviral genes Mtv-2 and Mtv-3 in mouse mammary gland. Int J Cancer 31: 217-221, 1983.
18. Nihrane A, Fujita K, Willey R, Soo Lyu M and Silver J: Murine leukemia virus envelope protein in transgenic-mouse serum blocks infection in vitro. J Virol 70: 1882-1889, 1996.
19. Canaani E, Dreazen O, Klar A, Rechavi G, Ram D, Cohen JB and Givol D: Activation of the c-mos oncogene in a mouse plasmacytoma by insertion of an endogenous intracisternal A-particle genome. Proc Natl Acad Sci USA 80: 7118-7122, 1983.
20. Morse B, Rotherg PG, South VJ, Spandorfer JM and Astrin SM: Insertional mutagenesis of the myc locus by a LINE-1 sequence in a human breast carcinoma. Nature 333: 87-90, 1988.
21. Miki Y, Nishisho I, Horii A, Miyoshi Y, Utsunomiya J, Kinzler KW, Vogelstein B and Nakamura Y: Disruption of the APC gene by a retrotransposal insertion of LI sequence in a colon cancer. Cancer Res 52: 643-645, 1992.
22. Tas MPR, Laarman D, de Haan-Meulman M, Balm AJM, Snow GB and Drexhage HA: Retroviral p15E-related serum factors and recurrence of head and neck cancer. Clin Otolaryngol 18: 324-328, 1993.
23. Benomar A, Ming WJ, Taraboletti G, Ghezzi P, Balotta C, Cianciolo GJ, Snyderman R, Doré J-F and Mantovani A: Chemotactic factor and P15E-related chemotaxis inhibitor in human melanoma cell lines with different macrophage content and tumorigenicity in nude mice. J Immunol 138: 2372-2379, 1987.
24. Mitreiter K, Schmidt J, Luz A, Atkinson MJ, Höfler H, Erfle V and Strauss PG: Disruption of the murine p53 gene by insertion of an endogenous retrovirus-like element (ETn) in a cell line from radiation-induced osteosarcoma. Virology 200: 837-841, 1994.